Ahmadi Bahram, Naeimi Behrouz, Ahmadipour Mohammad Javad, Morovati Hamid, de Groot Theun, Spruijtenburg Bram, Badali Hamid, Meis Jacques F
Department of Medical Laboratory Sciences, Faculty of Paramedical, Bushehr University of Medical Sciences, Bushehr 75187-59577, Iran.
Department of Ear, Nose & Throat (ENT), Dey Clinic, Bushehr 75187-59577, Iran.
J Fungi (Basel). 2023 Nov 11;9(11):1101. doi: 10.3390/jof9111101.
is a newly emerging multidrug-resistant fungal pathogen considered to be a serious global health threat. Due to diagnostic challenges, there is no precise estimate for the prevalence rate of this pathogen in Iran. Since 2019, only six culture-proven cases have been reported from Iran, of which, five belonged to clade V and one to clade I. Herein, we report a case of otomycosis due to from 2017 in a 78-year-old man with diabetes mellitus type II without an epidemiological link to other cases or travel history. Short tandem repeat genotyping and whole genome sequencing (WGS) analysis revealed that this isolate belonged to clade I of (South Asian Clade). The WGS single nucleotide polymorphism calling demonstrated that the isolate from 2017 is not related to a previously reported clade I isolate from Iran. The presence of this retrospectively recognized clade I isolate also suggests an early introduction from other regions or an autochthonous presence. Although the majority of reported isolates worldwide are resistant to fluconazole and, to a lesser extent, to echinocandins and amphotericin B, the reported clade I isolate from Iran was susceptible to all antifungal drugs.
是一种新出现的多重耐药真菌病原体,被认为是对全球健康的严重威胁。由于诊断方面的挑战,伊朗这种病原体的流行率尚无精确估计。自2019年以来,伊朗仅报告了6例经培养证实的病例,其中5例属于V分支,1例属于I分支。在此,我们报告一例2017年发生的由引起的耳真菌病病例,患者为一名78岁的II型糖尿病男性,与其他病例无流行病学关联,也无旅行史。短串联重复基因分型和全基因组测序(WGS)分析显示,该分离株属于(南亚分支)的I分支。WGS单核苷酸多态性分析表明,2017年的分离株与之前报道的来自伊朗的I分支分离株无关。这一追溯确认的I分支分离株的存在也表明其可能是早期从其他地区引入或本地存在。尽管全球报告的大多数分离株对氟康唑耐药,对棘白菌素和两性霉素B的耐药程度较低,但从伊朗报告的I分支分离株对所有抗真菌药物敏感。